Insiders · CATX

CATX insider transactions

Perspective Therapeutics Inc. (CATX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CATX

• 95d
  SEC Form 4 filed by Director Martinez Maria E

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 95d
  SEC Form 4 filed by Director Morich Frank

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 95d
  SEC Form 4 filed by Director Williamson Robert F Iii

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 95d
  SEC Form 4 filed by Director Henson Heidi

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 95d
  SEC Form 4 filed by Director Woods Lori A

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 95d
  SEC Form 4 filed by Chief Executive Officer Spoor Johan M.

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 95d
  SEC Form 4 filed by Chief Accounting Officer Hunt Jonathan Robert

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 95d
  SEC Form 4 filed by Chief Medical Officer Puhlmann Markus

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 203d
  Chief Accounting Officer Hunt Jonathan Robert bought $22,295 worth of shares (11,000 units at $2.03), increasing direct ownership by 23% to 59,800 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 206d
  Director Williamson Robert F Iii bought $19,946 worth of shares (9,498 units at $2.10) (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 276d
  SEC Form 4 filed by Chief Financial Officer Sendek Joel

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 276d
  SEC Form 3 filed by new insider Sendek Joel

  3 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 276d
  SEC Form 4 filed by Director Martinez Maria E

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 276d
  SEC Form 3 filed by new insider Martinez Maria E

  3 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 432d
  Chief Executive Officer Spoor Johan M. bought $59,673 worth of shares (26,676 units at $2.24), increasing direct ownership by 59% to 59,383 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 433d
  Director Williamson Robert F Iii bought $132,151 worth of shares (60,337 units at $2.19), increasing direct ownership by 124% to 108,982 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 433d
  Chief Financial Officer Graham Juan bought $74,946 worth of shares (33,333 units at $2.25), increasing direct ownership by 1,649% to 35,354 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 433d
  Director Woods Lori A bought $49,999 worth of shares (23,475 units at $2.13) (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 460d
  SEC Form 4 filed by Chief Medical Officer Puhlmann Markus

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 460d
  SEC Form 4 filed by Chief Accounting Officer Hunt Jonathan Robert

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 460d
  SEC Form 4 filed by Chief Executive Officer Spoor Johan M.

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 460d
  SEC Form 4 filed by Director Henson Heidi

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 460d
  SEC Form 4 filed by Director Williamson Robert F Iii

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 460d
  SEC Form 4 filed by Director Morich Frank

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 460d
  SEC Form 4 filed by Director Woods Lori A

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 516d
  SEC Form 4 filed by Chief Financial Officer Graham Juan

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 516d
  New insider Graham Juan claimed ownership of 2,021 shares (SEC Form 3)

  3 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 549d
  Director Henson Heidi bought $100,004 worth of shares (25,975 units at $3.85) (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 550d
  CEO Spoor Johan M. bought $30,132 worth of shares (8,000 units at $3.77), increasing direct ownership by 28% to 36,257 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 550d
  Amendment: SEC Form 4 filed by Director Williamson Robert F Iii

  4/A - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 550d
  Amendment: SEC Form 4 filed by CEO Spoor Johan M.

  4/A - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 558d
  Director Williamson Robert F Iii bought $22,814 worth of shares (6,266 units at $3.64), increasing direct ownership by 1% to 430,058 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 558d
  Chief Financial Officer Hunt Jonathan Robert bought $48,974 worth of shares (12,829 units at $3.82), increasing direct ownership by 36% to 48,800 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 559d
  CEO Spoor Johan M. bought $100,468 worth of shares (26,500 units at $3.79), increasing direct ownership by 11% to 152,072 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 689d
  SEC Form 4 filed by VP Finance/Prin Fin&Acct Offic Austin Mark John

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 714d
  SEC Form 4 filed by Director Williamson Robert F Iii

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 714d
  SEC Form 4 filed by Director Morich Frank

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 714d
  SEC Form 4 filed by Director Woods Lori A

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 714d
  SEC Form 4 filed by Director Henson Heidi

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 714d
  SEC Form 4 filed by CEO Spoor Johan M.

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 714d
  SEC Form 4 filed by Chief Medical Officer Puhlmann Markus

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 714d
  SEC Form 4 filed by Chief Financial Officer Hunt Jonathan Robert

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 720d
  Chief Financial Officer Hunt Jonathan Robert bought $17,667 worth of shares (1,800 units at $9.81), increasing direct ownership by 5% to 35,971 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 720d
  Director Woods Lori A bought $49,990 worth of shares (4,587 units at $10.90) (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 725d
  CEO Spoor Johan M. bought $117,430 worth of shares (100,000 units at $1.17), increasing direct ownership by 266% to 137,572 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 733d
  SEC Form 4 filed by Woods Lori A (Amendment)

  4/A - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 734d
  Woods Lori A bought $49,992 worth of shares (34,246 units at $1.46) (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 735d
  Hunt Jonathan Robert bought $35,007 worth of shares (25,006 units at $1.40), increasing direct ownership by 8% to 341,716 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 735d
  Williamson Robert F Iii bought $75,900 worth of shares (55,000 units at $1.38), increasing direct ownership by 15% to 423,792 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 739d
  Williamson Robert F Iii bought $40,014 worth of shares (30,031 units at $1.33), increasing direct ownership by 9% to 368,792 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)
• 775d
  Austin Mark John exercised 30,000 shares at a strike of $0.36, increasing direct ownership by 56% to 84,030 units (SEC Form 4)

  4 - Perspective Therapeutics, Inc. (0000728387) (Issuer)